These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1698 related articles for article (PubMed ID: 17435461)

  • 81. Prevalence of attention-deficit/hyperactivity disorder in a community sample of older adolescents.
    Cuffe SP; McKeown RE; Jackson KL; Addy CL; Abramson R; Garrison CZ
    J Am Acad Child Adolesc Psychiatry; 2001 Sep; 40(9):1037-44. PubMed ID: 11556627
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Sleep and alertness in children with ADHD.
    Lecendreux M; Konofal E; Bouvard M; Falissard B; Mouren-Siméoni MC
    J Child Psychol Psychiatry; 2000 Sep; 41(6):803-12. PubMed ID: 11039692
    [TBL] [Abstract][Full Text] [Related]  

  • 83. [Confirmation of the high prevalence of attention deficit disorder in a Colombian community].
    Pineda DA; Lopera F; Henao GC; Palacio JD; Castellanos FX;
    Rev Neurol; 2001 Feb 1-15; 32(3):217-22. PubMed ID: 11310271
    [TBL] [Abstract][Full Text] [Related]  

  • 84. [Psychopathology associated to attention deficit hyperactivity disorder in school age children].
    Ulloa RE; Sánchez S; Sauceda JM; Ortiz S
    Actas Esp Psiquiatr; 2006; 34(5):330-5. PubMed ID: 16991022
    [TBL] [Abstract][Full Text] [Related]  

  • 85. The prevalence of attention deficit-hyperactivity disorder in children with nonmonosymptomatic nocturnal enuresis: a 4-year followup study.
    Baeyens D; Roeyers H; Van Erdeghem S; Hoebeke P; Vande Walle J
    J Urol; 2007 Dec; 178(6):2616-20. PubMed ID: 17945295
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Omega-3/omega-6 fatty acids for attention deficit hyperactivity disorder: a randomized placebo-controlled trial in children and adolescents.
    Johnson M; Ostlund S; Fransson G; Kadesjö B; Gillberg C
    J Atten Disord; 2009 Mar; 12(5):394-401. PubMed ID: 18448859
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Acute impact of immediate release methylphenidate administered three times a day on sleep in children with attention-deficit/hyperactivity disorder.
    Corkum P; Panton R; Ironside S; Macpherson M; Williams T
    J Pediatr Psychol; 2008 May; 33(4):368-79. PubMed ID: 18056144
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Atomoxetine hydrochloride in the treatment of children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: A placebo-controlled Italian study.
    Dell'Agnello G; Maschietto D; Bravaccio C; Calamoneri F; Masi G; Curatolo P; Besana D; Mancini F; Rossi A; Poole L; Escobar R; Zuddas A;
    Eur Neuropsychopharmacol; 2009 Nov; 19(11):822-34. PubMed ID: 19716683
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Instability of the DSM-IV Subtypes of ADHD from preschool through elementary school.
    Lahey BB; Pelham WE; Loney J; Lee SS; Willcutt E
    Arch Gen Psychiatry; 2005 Aug; 62(8):896-902. PubMed ID: 16061767
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Longitudinal mapping of cortical thickness and clinical outcome in children and adolescents with attention-deficit/hyperactivity disorder.
    Shaw P; Lerch J; Greenstein D; Sharp W; Clasen L; Evans A; Giedd J; Castellanos FX; Rapoport J
    Arch Gen Psychiatry; 2006 May; 63(5):540-9. PubMed ID: 16651511
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Overweight in children and adolescents in relation to attention-deficit/hyperactivity disorder: results from a national sample.
    Waring ME; Lapane KL
    Pediatrics; 2008 Jul; 122(1):e1-6. PubMed ID: 18595954
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Mental health in the United States. Prevalence of diagnosis and medication treatment for attention-deficit/hyperactivity disorder--United States, 2003.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2005 Sep; 54(34):842-7. PubMed ID: 16138075
    [TBL] [Abstract][Full Text] [Related]  

  • 93. [Attention deficit hyperactivity disorder outcome in adults].
    Bange F
    Arch Pediatr; 2011 Jul; 18(7):831-4. PubMed ID: 21652189
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Behavior problems and subtypes of attention-deficit hyperactivity disorder with comorbidities.
    Tzang RF; Chang YC
    Kaohsiung J Med Sci; 2009 Oct; 25(10):530-6. PubMed ID: 19767258
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Rates of adherence to pharmacological treatment among children and adolescents with attention deficit hyperactivity disorder.
    Ibrahim el SR
    Hum Psychopharmacol; 2002 Jul; 17(5):225-31. PubMed ID: 12404679
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Relationship between traumatic dental injuries and attention-deficit/hyperactivity disorder in children and adolescents: proposal of an explanatory model.
    Sabuncuoglu O; Taser H; Berkem M
    Dent Traumatol; 2005 Oct; 21(5):249-53. PubMed ID: 16149918
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Attention-deficit/hyperactivity disorder: are we medicating for social disadvantage? (For).
    Isaacs D
    J Paediatr Child Health; 2006 Sep; 42(9):544-7. PubMed ID: 16925542
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Secondary Attention-Deficit/Hyperactivity Disorder in Children and Adolescents 5 to 10 Years After Traumatic Brain Injury.
    Narad ME; Kennelly M; Zhang N; Wade SL; Yeates KO; Taylor HG; Epstein JN; Kurowski BG
    JAMA Pediatr; 2018 May; 172(5):437-443. PubMed ID: 29554197
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Adults with ADHD. An overview.
    Wender PH; Wolf LE; Wasserstein J
    Ann N Y Acad Sci; 2001 Jun; 931():1-16. PubMed ID: 11462736
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Attention-deficit hyperactivity disorder and blood mercury level: a case-control study in Chinese children.
    Cheuk DK; Wong V
    Neuropediatrics; 2006 Aug; 37(4):234-40. PubMed ID: 17177150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 85.